Literature DB >> 12534347

The pro-urokinase plasminogen-activation system in the presence of serpin-type inhibitors and the urokinase receptor: rescue of activity through reciprocal pro-enzyme activation.

Niels Behrendt1, Karin List, Peter A Andreasen, Keld Danø.   

Abstract

The reciprocal pro-enzyme activation system of plasmin, urokinase-type plasminogen activator (uPA) and their respective zymogens is a potent mechanism in the generation of extracellular proteolytic activity. Plasminogen activator inhibitor type 1 (PAI-1) acts as a negative regulator. This system is complicated by a poorly understood intrinsic reactivity of the uPA pro-enzyme (pro-uPA) before proteolytic activation, directed against both plasminogen and PAI-1. We have studied the integrated activation mechanism under the repression of PAI-1 in a purified system. A covalent reaction between pro-uPA and PAI-1 was positively demonstrated but the reaction of PAI-1 with two-chain uPA was found to be at least 1000-fold faster. However, in spite of this very fast inhibition, two-chain uPA still became the dominant plasminogen activator when plasminogen was incubated with pro-uPA and PAI-1. The activity pattern observed under these conditions revealed an initial lag phase, followed by a continuous generation of minute amounts of active two-chain uPA, this uPA having a short lifetime before inhibition but still succeeding to generate new plasmin activity, thus preventing a complete inactivation of the feedback system. This property of the activation system was retained even in the simultaneous presence of PAI-1 and alpha(2)-antiplasmin. Addition of soluble uPA receptor to the system did not change the role of pro-uPA and the same pattern was observed when pro-uPA was bound to the uPA receptor on U937 cells. The present mechanism maintains the system at standby level and may be triggered to increased activity without the need for an external initiating event.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534347      PMCID: PMC1223308          DOI: 10.1042/BJ20021508

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  A urokinase receptor-associated protein with specific collagen binding properties.

Authors:  N Behrendt; O N Jensen; L H Engelholm; E Mørtz; M Mann; K Danø
Journal:  J Biol Chem       Date:  2000-01-21       Impact factor: 5.157

2.  Structure of a serpin-protease complex shows inhibition by deformation.

Authors:  J A Huntington; R J Read; R W Carrell
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

3.  Serpin-protease complexes are trapped as stable acyl-enzyme intermediates.

Authors:  D A Lawrence; D Ginsburg; D E Day; M B Berkenpas; I M Verhamme; J O Kvassman; J D Shore
Journal:  J Biol Chem       Date:  1995-10-27       Impact factor: 5.157

4.  Urokinase-type plasminogen activator and its receptor synergize to promote pathogenic proteolysis.

Authors:  H M Zhou; A Nichols; P Meda; J D Vassalli
Journal:  EMBO J       Date:  2000-09-01       Impact factor: 11.598

Review 5.  The plasminogen activation system in tumor growth, invasion, and metastasis.

Authors:  P A Andreasen; R Egelund; H H Petersen
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

6.  Interaction of single-chain urokinase and plasminogen activator inhibitor type 1.

Authors:  N Manchanda; B S Schwartz
Journal:  J Biol Chem       Date:  1995-08-25       Impact factor: 5.157

7.  Enhancement of the enzymatic activity of single-chain urokinase plasminogen activator by soluble urokinase receptor.

Authors:  A Higazi; R L Cohen; J Henkin; D Kniss; B S Schwartz; D B Cines
Journal:  J Biol Chem       Date:  1995-07-21       Impact factor: 5.157

8.  Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.

Authors:  H R Lijnen; F De Cock; D Collen
Journal:  Eur J Biochem       Date:  1994-09-01

9.  The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex.

Authors:  M Wilczynska; M Fa; P I Ohlsson; T Ny
Journal:  J Biol Chem       Date:  1995-12-15       Impact factor: 5.157

10.  Single-chain urokinase-type plasminogen activator bound to its receptor is relatively resistant to plasminogen activator inhibitor type 1.

Authors:  A A Higazi; A Mazar; J Wang; R Reilly; J Henkin; D Kniss; D Cines
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

View more
  9 in total

1.  Targeting the autolysis loop of urokinase-type plasminogen activator with conformation-specific monoclonal antibodies.

Authors:  Kenneth A Botkjaer; Sarah Fogh; Erin C Bekes; Zhuo Chen; Grant E Blouse; Janni M Jensen; Kim K Mortensen; Mingdong Huang; Elena Deryugina; James P Quigley; Paul J Declerck; Peter A Andreasen
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

2.  Urokinase links plasminogen activation and cell adhesion by cleavage of the RGD motif in vitronectin.

Authors:  Valentina De Lorenzi; Gian Maria Sarra Ferraris; Jeppe B Madsen; Michela Lupia; Peter A Andreasen; Nicolai Sidenius
Journal:  EMBO Rep       Date:  2016-05-17       Impact factor: 8.807

3.  Activation of pro-uPA is critical for initial escape from the primary tumor and hematogenous dissemination of human carcinoma cells.

Authors:  Erin M Bekes; Elena I Deryugina; Tatyana A Kupriyanova; Ewa Zajac; Kenneth A Botkjaer; Peter A Andreasen; James P Quigley
Journal:  Neoplasia       Date:  2011-09       Impact factor: 5.715

4.  Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits.

Authors:  Andrey A Komissarov; Andrew P Mazar; Kathy Koenig; Anna K Kurdowska; Steven Idell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-08-07       Impact factor: 5.464

5.  A novel mode of intervention with serine protease activity: targeting zymogen activation.

Authors:  Grant E Blouse; Kenneth A Bøtkjaer; Elena Deryugina; Aleksandra A Byszuk; Janni M Jensen; Kim K Mortensen; James P Quigley; Peter A Andreasen
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

Review 6.  Human plasma kallikrein-kinin system: physiological and biochemical parameters.

Authors:  J W Bryant; Z Shariat-Madar
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2009-07

7.  Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis.

Authors:  Ji-Hye Lee; Mee-Hye Oh; Jae-Seok Park; Gyoung-Jae Na; Hye-Wook Gil; Jong-Oh Yang; Eun-Young Lee; Sae-Yong Hong
Journal:  Korean J Intern Med       Date:  2014-02-27       Impact factor: 2.884

8.  Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.

Authors:  Gillian E Stillfried; Darren N Saunders; Marie Ranson
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

9.  A candidate activation pathway for coagulation factor VII.

Authors:  Tina M Misenheimer; Kraig T Kumfer; Barbara E Bates; Emily R Nettesheim; Bradford S Schwartz
Journal:  Biochem J       Date:  2019-10-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.